In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Bayer getting out of prescription dermatology, selling business to Leo Pharma

Executive Summary

Bayer AG sold Leo Pharma AS its global prescription dermatology business, including 450 employees. (The business is assumed to be the former Intendis division, later renamed Dermatology Inc. and absorbed into Bayer HealthCare LLC.) The deal excludes rights to the products in Afghanistan and Pakistan. Bayer’s OTC dermatology portfolio (which contains Bepanthen, Canesten, and others) is also not part of the agreement.
Deal Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Acquisition
    • Divestiture/Spin-Out

Related Companies